OMNIPAQUE 300 Rx
Generic Name and Formulations:
Iohexol 647mg (equivalent to 300mg of organic iodine) per mL; soln; preservative-free.
Indications for OMNIPAQUE 300:
For intrathecal administration in adults including myelography (lumbar, thoracic, cervical, total columnar) and in contrast enhancement for computerized tomography (myelography, cisternography, ventriculography). IV: In adults, for aortography including studies of the aortic arch, abdominal aorta and its branches, contrast enhancement for computed tomographic head and body imaging, cerebral arteriography, peripheral venography (phlebography), and excretory urography. In children, for angiocardiography (ventriculography), excretory urography, and contrast enhancement for computed tomographic head imaging. Oral/body cavity use: In adults, for arthrography and hysterosalpingography. In children, for examination of the gastrointestinal tract.
Adults and Children:
See literature for dosing based on procedure.
Local or systemic infection (w. myelography). Concomitant corticosteroids with intrathecal administration. Immediate repeat myelography in the event of technical failure. Hysterosalpingography: during menstrual period or when menstural flow is imminent; genital tract infection, pregnant women.
Do not administer Omnipaque 350 intrathecally: severe reactions may occur (eg, death, convulsion, cerebral hemorrhage, coma, paralysis, arachnoiditis, acute renal failure, cardiac arrest, seizures, rhabdomyolysis, hyperthermia, brain edema). To be used by trained personnel in appropriate facilities. History of epilepsy. Severe cardiovascular disease. Chronic alcoholism. Multiple sclerosis. Diabetes. Multiple myeloma. Carcinoma. Resistant anuria. Pheochromocytoma. Homozygous sickle cell disease. Homocystinuria: avoid. Chronic pulmonary emphysema. Thyroid disorder. Patients with evidence of inadvertant intracranial entry of large or concentrated bolus of contrast medium: increased risk of seizures; consider prophylactic barbiturate therapy. Direct intracisternal or ventricular administration for standard radiography: not recommended. Maintain elevation of head during procedure, on the stretcher, or in bed. Avoid excessive and active patient movement or straining. Hepatic or renal impairment. Renal transplant recipients. Elderly. Pregnancy (Cat.B). Nursing mothers: bottle feeding may be substituted for breast feeding for 24hrs following administration.
Concomitant drugs that lower seizure threshold (eg, phenothiazines, MAOIs, tricyclics, CNS stimulants, analeptics, major tranquilizers, antipsychotics): not recommended; discontinue 48hrs and for at least 24hrs post-procedure. May reduce iodine-binding capacity of thyroid tissue for up to 2 weeks.
Radiographic contrast medium.
Intrathecal: headache, backache, neckache, stiffness, GI upset; allergic reactions (may be severe). IV: inj site reactions, arrhythmias, angina/chest pain, hypotension, vertigo, vision abnormalities, headache, taste perversion, GI upset. Body cavities: pain, swelling, heat. Oral: diarrhea, nausea, vomiting, abdominal pain, flatulence, headache; children: also, fever, hypotension, urticaria. Arthrography: joint pain/swelling, heat sensation. ERP/ERCP: transient pain, hypertension, somnolence, burning, GI upset. Hysterosalpingography: transient pain, somnolence, fever, nausea. Herniography: pain, headache, unwell feeling, diarrhea, flatulence.
Omnipaque 240 (200mL)—10; Omnipaque 300 (200mL, 500mL)—10; Omnipaque 350 (500mL)—10
Psychiatry Advisor Articles
- Continuing Research, Emerging Treatments Hold Promise for Treating Anorexia Nervosa
- ACOG Update: Marijuana Use Discouraged During Pregnancy, Breastfeeding
- Asenapine Prevents Recurrence of Mood Events in Bipolar Disorder
- Depression Profiles in Patients With Type 1 Diabetes vs Type 2 Diabetes
- Purpose, Questions of Social Interaction Lead Physicians to Delay Retirement
- CBT, Acceptance Commitment Therapy Helpful for Those With Chronic Pain
- Suicidal Behavior, Thoughts Associated With Perfectionist Tendencies
- Depression Reduced by Social Belonging, Feelings of Inclusion
- Sleep Disturbance May Be Causal Factor in Psychotic Experiences
- Is Antidepressant Use in Pregnancy Tied to Psychiatric Disorders in Offspring?
- Cardiovascular Risk Management May Slow Neurocognitive Decline in HIV
- Maintenance rTMS for Treatment-Resistant Depression
- New Study Compares Opioid Dependence Relapse Treatments
- Increase Use of Nursing Home for Patients With Cognitive Impairment Category
- Venlafaxine XR Safe, Effective in Treating Generalized Anxiety Disorder